Karisalankanni (Eclipta prostrata)

Karisalankanni (Eclipta prostrata) is a traditional Siddha medicine herb containing high levels of saponins (84.175 mg/g) and polyphenols with potential hepatoprotective properties. The plant's bioactive compounds may support liver function through antioxidant mechanisms, though clinical evidence remains limited.

Origin & History

Karisalankanni (Eclipta prostrata) is a prostrate annual herb native to tropical and subtropical regions, particularly India, where it has been used in Ayurvedic and Siddha medicine for centuries. The plant is typically harvested for its leaves and aerial parts, with active compounds extracted using methanol for phytochemical analysis.

Historical & Cultural Context

Known as Bhringraj in Ayurveda, Karisalankanni has been used for centuries in Indian traditional medicine systems including Siddha for liver health, inflammation, and skin conditions. The herb has various regional names including Jala Bhangara in Malayalam and Kehraj in Assamese, reflecting its widespread traditional use across India.

Health Benefits

• May support liver health through hepatoprotective and hepatotonic properties (traditional use evidence only)
• Contains antioxidant compounds including saponins (84.175 mg/g) and polyphenols (preliminary in vitro evidence)
• Traditionally used for anti-inflammatory and analgesic effects (no clinical trials available)
• May provide antimicrobial activity against certain bacteria (in vitro studies only)
• Rich in nutrients including 19.68% crude protein and vitamins E and C (compositional analysis)

How It Works

Karisalankanni's hepatoprotective effects are attributed to its high saponin content (84.175 mg/g) and polyphenolic compounds that demonstrate antioxidant activity in preliminary studies. These bioactive compounds may protect hepatocytes from oxidative stress by scavenging free radicals and supporting cellular antioxidant enzyme systems. The anti-inflammatory properties are likely mediated through inhibition of pro-inflammatory cytokines, though specific molecular pathways require further investigation.

Scientific Research

No human clinical trials, RCTs, or meta-analyses have been conducted on Karisalankanni according to available research. Current evidence is limited to phytochemical screening studies and in vitro antioxidant and antibacterial assays using methanolic leaf extracts.

Clinical Summary

Current evidence for Karisalankanni is primarily based on traditional use in Siddha medicine and preliminary in vitro studies showing antioxidant activity. No randomized controlled trials have been published evaluating its hepatoprotective effects in humans. Laboratory studies have quantified saponin content at 84.175 mg/g, but clinical translation of these findings remains unestablished. The evidence strength is considered low, relying mainly on traditional knowledge and basic phytochemical analysis.

Nutritional Profile

{"macronutrients": {"protein": "3.2 g/100 g", "fiber": "5.4 g/100 g"}, "micronutrients": {"calcium": "300 mg/100 g", "iron": "10 mg/100 g", "vitamin_C": "4 mg/100 g"}, "bioactive_compounds": {"saponins": "84.175 mg/g", "polyphenols": "quantitative data not specified"}, "bioavailability_notes": "The bioavailability of these compounds can vary based on preparation methods and individual digestive health. Saponins and polyphenols may have reduced absorption due to their complex structures."}

Preparation & Dosage

No clinically studied dosage ranges, standardized extracts, or optimal forms (powder, extract) have been established for Karisalankanni. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Milk Thistle, Turmeric, Phyllanthus niruri, Picrorhiza kurroa, Andrographis paniculata

Safety & Interactions

Safety data for Karisalankanni supplementation is limited, with no established adverse effect profile or drug interaction studies. Traditional use suggests general tolerability, but specific contraindications have not been systematically evaluated. Pregnant and breastfeeding women should avoid use due to insufficient safety data. Individuals with liver conditions should consult healthcare providers before use, as herb-drug interactions with hepatically metabolized medications remain unknown.